Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder

This study has been completed.
Information provided by (Responsible Party):
Neurocrine Biosciences Identifier:
First received: July 11, 2011
Last updated: May 7, 2013
Last verified: May 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2012
  Primary Completion Date: February 2012 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: April 30, 2013